| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | 784,159 | 25,462,000 | 18.33% | ||
| 2 | VERSARTIS INC COM | 2,039,223 | 24,980,000 | 17.98% | ||
| 3 | EDGE THERAPEUTICS INC | 2,344,868 | 24,410,000 | 17.57% | ||
| 4 | Oxford Immunotec Global PLC | 1,377,497 | 17,301,000 | 12.46% | ||
| 5 | DIMENSION THERAPEUTICS INC COM | 2,059,283 | 16,454,000 | 11.85% | ||
| 6 | ALDER BIOPHARMACEUTICALS INC | 230,954 | 7,568,000 | 5.45% | ||
| 7 | DERMIRA INC | 193,944 | 6,559,000 | 4.72% | ||
| 8 | SAGE THERAPEUTICS | 132,674 | 6,110,000 | 4.40% | ||
| 9 | DYNAVAX TECHNOLOGIES CORP | 400,381 | 4,200,000 | 3.02% | ||
| 10 | AVEO PHARMACEUTICALS INC | 2,590,673 | 2,306,000 | 1.66% | ||
| 11 | VistaGen Therapeutics Inc | 352,950 | 1,493,000 | 1.07% | ||
| 12 | TRILLIUM THERAPEUTICS INC | 80,759 | 1,193,000 | 0.86% | ||
| 13 | INOTEK PHARMACEUTICALS CORP | 50,300 | 477,000 | 0.34% | ||
| 14 | ADAPTIMMUNE THERAPEUTICS PLC | 55,008 | 388,000 | 0.28% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001631614-16-000007, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
